Level of ATP in patient cells treated for 24 hours with control, tofacitinib (tof), ruxolitinib (ruxol), doxorubicin or a combination of tofacitinib and ruxolitinib. There is synergistic depression of cell metabolism and growth for cells treated with both tofacitinib and ruxolitinib.